Fly News Breaks for February 27, 2015
CTSH
Feb 27, 2015 | 07:39 EDT
Cognizant remains a top pick at Goldman given outsized revenue growth as a result of strong spending in the Healthcare segment, combined with synergies from the TriZetto acquisition. The firm expects strong revenue growth and share gains will drive multiple expansion. Shares are Conviction Buy rated with a $68 price target.
News For CTSH From the Last 2 Days